HIGHLIGHTS
- who: MTOR signaling and collaborators from the University of Firenze, Italy have published the research work: Identi fi cation of therapeutic targets and prognostic biomarkers among frizzled family genes in glioma, in the Journal: (JOURNAL)
- what: Our preliminary findings revealed that FZD1/2/5/6/ 7/8 may be a disadvantageous factor for glioma, whereas FZD2/6 may serve as a novel independent predictor of poor prognosis.
- how: The results showed that high expression of FZD1/2/5/6/7/8/10 was positively correlated with the dead group (OS event) and FZD9 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.